Is ecstasy (MDMA) use associated with symptoms of anxiety or depression among incarcerated juvenile offenders?

Michael G. Vaughn, Matthew O. Howard, Mary P. Curtis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Adolescent ecstasy (MDMA) use in the U.S. has increased more than 230 percent over the past decade. Results from animal studies indicating that ecstasy is damaging to serotonin-releasing neurons and anecdotal reports describing persistent anxiety among heavy adult ecstasy users have led to growing concerns about the role ecstasy use may play in adolescent anxiety and depressive disorders. This study examined the prevalence of ecstasy use among 104 incarcerated youth and the associations of lifetime frequency of ecstasy use with various measures of current psychopathology. A total of 43 (41.3%) youth reported lifetime ecstasy use. Lifetime frequency of ecstasy use was significantly positively (r =.25, p <.05) associated with current severity of anxiety symptoms. Multiple linear regression models controlling for polydrug use revealed that ecstasy use might not be as uniquely harmful as initial animal, case, and media reports have suggested. Study limitations, practice implications, and future research directions relevant to ecstasy use among juvenile offenders are discussed.

Original languageEnglish
Pages (from-to)19-34
Number of pages16
JournalJournal of Evidence-Based Social Work
Volume2
Issue number3-4
DOIs
Publication statusPublished - 2005 Sep 12

All Science Journal Classification (ASJC) codes

  • Human Factors and Ergonomics
  • Sociology and Political Science

Fingerprint Dive into the research topics of 'Is ecstasy (MDMA) use associated with symptoms of anxiety or depression among incarcerated juvenile offenders?'. Together they form a unique fingerprint.

  • Cite this